BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38253629)

  • 41. A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.
    Han X; Liang L; He C; Ren Q; Su J; Cao L; Zheng J
    BMC Complement Med Ther; 2023 Nov; 23(1):422. PubMed ID: 37990309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Zhisou powder displays therapeutic effect on chronic bronchitis through inhibiting PI3K/Akt/HIF-1α/VEGFA signaling pathway and reprograming metabolic pathway of arachidonic acid.
    Dong Y; Liu Y; Tang J; Du J; Zhuang X; Tan S; Yang Y; Yin D
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117110. PubMed ID: 37673198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study on molecular biological mechanism of Chinese herbal medicines for the treatment of gastric precancerous lesions based on data mining and network pharmacology.
    Zhang Q; Liu N; Wu D; Xu Z; Wang Y; Wang P
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 51(5):573-584. PubMed ID: 36581572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The inhibitory effect and mechanism of Resina Draconis on the proliferation of MCF-7 breast cancer cells: a network pharmacology-based analysis.
    Lv Y; Mou Y; Su J; Liu S; Ding X; Yuan Y; Li G; Li G
    Sci Rep; 2023 Mar; 13(1):3816. PubMed ID: 36882618
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Naringenin inhibits migration of bladder cancer cells through downregulation of AKT and MMP‑2.
    Liao AC; Kuo CC; Huang YC; Yeh CW; Hseu YC; Liu JY; Hsu LS
    Mol Med Rep; 2014 Sep; 10(3):1531-6. PubMed ID: 25017119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrated strategy of network pharmacology, molecular docking, HPLC-DAD and mice model for exploring active ingredients and pharmacological mechanisms of Penthorum chinense Pursh against alcoholic liver injury.
    Jiang Y; Zhong M; Zhan H; Tao X; Zhang Y; Mao J; Geng Z; Gao B
    J Ethnopharmacol; 2022 Nov; 298():115589. PubMed ID: 35926779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrated network pharmacology and experimental verification to explore the molecular mechanism of Jingxin Zhidong formula for treating Tic disorder.
    Tian X; Ou G; Hu S; Wang C; Han F; Gao L
    J Ethnopharmacol; 2023 Apr; 305():116114. PubMed ID: 36587455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Mechanism of Zhongfeng Xingnao Decoction in improving microcirculatory disorders in cerebral hemorrhage based on network pharmacology and molecular docking techniques].
    Zhong XQ; Hu DF; Wang Y; Ning ZQ; Deng MZ
    Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(22):6115-6127. PubMed ID: 38114219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrating Network Pharmacology and Experimental Validation to Elucidate the Mechanism of Yiqi Yangyin Decoction in Suppressing Non-Small-Cell Lung Cancer.
    Jiao P; Wang Y; Ren G; Chu D; Li Y; Sang T
    Biomed Res Int; 2023; 2023():4967544. PubMed ID: 36874921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The mechanism of Chebulae Fructus Immaturus promote diabetic wound healing based on network pharmacology and experimental verification.
    Qiu F; Fan S; Diao Y; Liu J; Li B; Li K; Zhang W
    J Ethnopharmacol; 2024 Mar; 322():117579. PubMed ID: 38104882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
    Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms of action of Fu Fang Gang Liu liquid in treating condyloma acuminatum by network pharmacology and experimental validation.
    Fan Z; Wang S; Xu C; Yang J; Cui B
    BMC Complement Med Ther; 2023 Apr; 23(1):128. PubMed ID: 37081536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
    Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of
    Kang YH; Zhou T; Wu SX; Li XJ; Huang XY; Xia R; Ling YH; Zhou HT; Zhang SW; Yin WY
    Am J Chin Med; 2023; 51(6):1477-1499. PubMed ID: 37530508
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect and mechanism of Banxia Xiexin decoction in colorectal cancer: A network pharmacology approach.
    Wang Y; Zhao T; Huang C; Liu F; Zhang Y; Kong D; Fan Z
    Phytomedicine; 2024 Jan; 123():155174. PubMed ID: 38039904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integrated Network Pharmacology Analysis and Experimental Validation to Investigate the Molecular Mechanism of Triptolide in the Treatment of Membranous Nephropathy.
    Zhang PN; Tang JY; Yang KZ; Zheng QY; Dong ZC; Geng YL; Liu YN; Liu WJ
    Drug Des Devel Ther; 2022; 16():4061-4076. PubMed ID: 36448035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exploration of the effect and mechanism of Scutellaria barbata D. Don in the treatment of ovarian cancer based on network pharmacology and in vitro experimental verification.
    Zhang J; Qi C; Li H; Ding C; Wang L; Wu H; Dai W; Wang C
    Medicine (Baltimore); 2023 Dec; 102(51):e36656. PubMed ID: 38134066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular docking, network pharmacology and experimental verification to explore the mechanism of Wulongzhiyangwan in the treatment of pruritus.
    Anqi L; Shijun S
    Sci Rep; 2023 Jan; 13(1):361. PubMed ID: 36611103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.
    Yan SP; Chu DX; Qiu HF; Xie Y; Wang CF; Zhang JY; Li WC; Guo RX
    J Cell Mol Med; 2019 Apr; 23(4):2656-2666. PubMed ID: 30697971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Mechanism of Astragali Radix-Curcumae Rhizoma in treating gastric cancer based on network pharmacology and experimental verification].
    Tan XY; Tao J; Zhang Y; Gu RX
    Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):5056-5067. PubMed ID: 37802848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.